Equities

AI Healthcare Boom: BNAI Aims High with $148B Forecast by 2029

AI in Healthcare to Surge to $148 Billion by 2029, with BEN Leading the Revolution through Strategic Partnerships and Innovation

By Bill Bullington

4/25, 08:29 EDT
article-main-img

Key Takeaway

  • AI in healthcare market projected to grow from $20.9 billion in 2024 to $148.4 billion by 2029, a CAGR of 48.1%.
  • Brand Engagement Network (NASDAQ: BNAI) partners with OSF HealthCare and MedAdvisor Solutions, enhancing patient care through AI.
  • Telehealth and generative AI technologies like OpenCRISPR-1 are revolutionizing access to care and gene editing, respectively.

AI's Expanding Role in Healthcare

The healthcare industry is witnessing a significant transformation with the integration of Artificial Intelligence (AI), which is streamlining administrative tasks, enhancing diagnostics, and enabling personalized medicine. The global AI in healthcare market, valued at $20.9 billion in 2024, is projected to reach $148.4 billion by 2029, growing at a CAGR of 48.1%. This growth is attributed to AI's ability to optimize treatment plans and predict healthcare outcomes, making healthcare delivery more efficient and effective.

Strategic Partnerships Enhance AI Applications

Brand Engagement Network (BEN) is at the forefront of integrating AI within the healthcare sector, aiming to address challenges such as human error and professional burnout. BEN's collaborations with OSF HealthCare and MedAdvisor Solutions underscore the potential of AI in improving patient care and healthcare operations. OSF HealthCare's partnership focuses on utilizing AI assistants for medical training and patient interaction, while MedAdvisor Solutions aims to leverage AI for better patient education on medication regimens. These partnerships reflect the industry's move towards adopting advanced AI tools for a more personalized and efficient healthcare experience.

Telehealth and AI Revolutionize Patient Care

Telehealth, bolstered by AI, is bridging the gap in healthcare accessibility, especially in rural areas facing physician shortages. Companies like Cardio Diagnostics are utilizing AI and telehealth to enhance access to cardiovascular care, addressing the leading cause of death in the U.S. The integration of AI in telehealth services is not only making specialty care more accessible but also improving the quality and convenience of care for patients in underserved regions.

Generative AI Pioneers New Frontiers in Gene Editing

Generative AI technologies are paving the way for groundbreaking advancements in gene editing. Profluent's development of AI-generated gene editors, such as OpenCRISPR-1, highlights the potential of AI in creating more precise and effective gene editing tools. While these technologies hold promise for transforming the treatment of genetic diseases, their practical application in healthcare is pending clinical trials. The collaborative effort to open source AI-generated gene editors exemplifies the scientific community's commitment to accelerating technological development in gene editing.

Management Quotes

  • Michael Zacharski, CEO of BEN:

    "We're excited to work with OSF HealthCare piloting our AI technology in medical professional and continuing education settings. BEN's goal is to create rich and engaging customer experiences and empower organizations with new tools that can accelerate business productivity and efficiency with our AI technology. This collaboration with OSF HealthCare brings voice powered AI Assistants to the forefront, benefitting medical professionals in a way that directly translates to improved patient experiences in everyday healthcare environments." "By partnering with MedAdvisor Solutions, we are opening the door to a wealth of opportunity across the healthcare space. Customers trust BEN to deploy a highly advanced, mature AI assistant as a next-generation conversational tool that can replace chatbots for organizations of all sizes. The AI assistant exists to provide an educational environment and an unrushed personal conversation about medication regimens to improve the experience of the customer, retail pharmacy chain, and the pharmaceutical manufacturer. We're beyond thrilled to be applying our technology to assist patients and elevate their healthcare experience."